🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer regulations, risking penalties, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the platform has taken down violative content and banned associated keywords and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, messages display black plastic packages with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these online products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially significant medical dangers”.